Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 2
2004 1
2005 4
2006 1
2007 1
2008 1
2009 6
2010 2
2011 3
2012 6
2013 1
2014 5
2016 1
2017 1
2018 1
2019 4
2020 5
2021 2
2022 2
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

42 results

Results by year

Filters applied: . Clear all
Page 1
Outcomes of a Diagnostic Pathway for Prostate Cancer Based on Biparametric MRI and MRI-Targeted Biopsy Only in a Large Teaching Hospital.
Paulino Pereira LJ, Reesink DJ, de Bruin P, Gandaglia G, van der Hoeven EJRJ, Marra G, Prinsen A, Rajwa P, Soeterik T, Kasivisvanathan V, Wever L, Zattoni F, van Melick HHE, van den Bergh RCN; EAU-YAU Prostate Cancer Working Group. Paulino Pereira LJ, et al. Among authors: de bruin p. Cancers (Basel). 2023 Sep 29;15(19):4800. doi: 10.3390/cancers15194800. Cancers (Basel). 2023. PMID: 37835494 Free PMC article.
Reply by Authors.
van Kalmthout LWM, van Melick HHE, Lavalaye J, Meijer RP, Kooistra A, de Klerk JMH, Braat AJAT, Kaldeway HP, de Bruin PC, de Keizer B, Lam MGEH. van Kalmthout LWM, et al. Among authors: de bruin pc. J Urol. 2020 Mar;203(3):545. doi: 10.1097/JU.0000000000000531.02. Epub 2019 Dec 3. J Urol. 2020. PMID: 31794357 No abstract available.
Prospective Validation of Gallium-68 Prostate Specific Membrane Antigen-Positron Emission Tomography/Computerized Tomography for Primary Staging of Prostate Cancer.
van Kalmthout LWM, van Melick HHE, Lavalaye J, Meijer RP, Kooistra A, de Klerk JMH, Braat AJAT, Kaldeway HP, de Bruin PC, de Keizer B, Lam MGEH. van Kalmthout LWM, et al. Among authors: de bruin pc. J Urol. 2020 Mar;203(3):537-545. doi: 10.1097/JU.0000000000000531. Epub 2019 Sep 6. J Urol. 2020. PMID: 31487220
Is There Still a Need for Repeated Systematic Biopsies in Patients with Previous Negative Biopsies in the Era of Magnetic Resonance Imaging-targeted Biopsies of the Prostate?
Exterkate L, Wegelin O, Barentsz JO, van der Leest MG, Kummer JA, Vreuls W, de Bruin PC, Bosch JLHR, van Melick HHE, Somford DM. Exterkate L, et al. Among authors: de bruin pc. Eur Urol Oncol. 2020 Apr;3(2):216-223. doi: 10.1016/j.euo.2019.06.005. Epub 2019 Jun 22. Eur Urol Oncol. 2020. PMID: 31239236
The FUTURE Trial: A Multicenter Randomised Controlled Trial on Target Biopsy Techniques Based on Magnetic Resonance Imaging in the Diagnosis of Prostate Cancer in Patients with Prior Negative Biopsies.
Wegelin O, Exterkate L, van der Leest M, Kummer JA, Vreuls W, de Bruin PC, Bosch JLHR, Barentsz JO, Somford DM, van Melick HHE. Wegelin O, et al. Among authors: de bruin pc. Eur Urol. 2019 Apr;75(4):582-590. doi: 10.1016/j.eururo.2018.11.040. Epub 2018 Dec 3. Eur Urol. 2019. PMID: 30522912 Clinical Trial.
42 results